Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00247572
Status:
COMPLETED
Last Update Posted:
2007-11-04
First Post:
2005-10-31
Brief Title:
Safety Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories
Sponsor:
New River Pharmaceuticals
Organization:
New River Pharmaceuticals
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Substance-Related Disorders |
| Attention Deficit Disorder With Hyperactivity |
| Amphetamine-Related Disorders |
Keywords:
| Name | View |
|---|---|
| Intravenous Drug Abuse | View |
| d-Amphetamine | View |
| Attention Deficit Hyperactivity Disorder | View |
| Attention Deficit Disorders with Hyperactivity | View |
| Attention Deficit Hyperactivity Disorders | View |
| Amphetamine Abuse | View |
| Amphetamine Dependence | View |
| Amphetamine Addiction | View |
| Amphetamine Users | View |
| Drug Abuse | View |
| Drug Addiction | View |
| Drug Dependence | View |
| Drug Habituation | View |
| Drug Use Disorders | View |
| Substance Abuse | View |
| Substance Dependence | View |
| Substance Use Disorders | View |
| Drug Usage | View |
| Substance Addiction | View |
| Drug Abuse Intravenous | View |